mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.01 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |